Abstract

ObjectiveWe aimed to analyze the perioperative, functional, and oncologic outcomes following robot-assisted radical prostatectomy (RARP) and laparoscopic radical prostatectomy (LRP) for patients with localized prostate cancer (PCa) characterized by a large prostate volume (PV; ≥50 ml) over a minimum of 2 years follow-up.Materials and MethodsPatients undergoing RARP and LRP for localized PCa with a large PV were included in the final analysis. The perioperative, functional, and oncologic outcomes were analyzed between the two groups.ResultsAll operations were successfully completed without open conversion in both groups. The mean operative time and estimated blood loss in the RARP group were significantly decreased compared to those in the LRP group (139.4 vs. 159.0 min, p = 0.001, and 124.2 vs. 157.3 ml, p = 0.003, respectively). Patients in the RARP arm had significantly lower proportions of grade II or lower and of higher than grade II postoperative complications compared with those in the LRP group (7.9% vs. 17.1%, p = 0.033, and 1.6% vs. 6.7%, p = 0.047, respectively). No significant differences in terms of the rates of pT3 disease, positive surgical margin, and positive lymph node were noted between the two groups. Moreover, no significant difference in the median specimen Gleason score was observed between the RARP and LRP groups (6 vs. 7, p = 0.984). RARP vs. LRP resulted in higher proportions of urinary continence upon catheter removal (48.4% vs. 33.3%, p = 0.021) and at 3 (65.1% vs. 50.5%, p = 0.025) and 24 (90.5% vs. 81.0%, p = 0.037) months post-operation. The median erectile function scores at 6 and 24 months post-operation in the RARP arm were also significantly higher than those in the LRP arm (15 vs. 15, p = 0.042, and 15 vs. 13, p = 0.026, respectively). Kaplan–Meier analyses indicated that the biochemical recurrence-free survival and accumulative proportion of continence were statistically comparable between the two groups (p = 0.315 and p = 0.020, respectively).ConclusionsFor surgically managing localized PCa with a large prostate (≥50 ml), RARP had a tendency toward a lower risk of postoperative complications and better functional preservation without cancer control being compromised when compared to LRP.

Highlights

  • Prostate cancer (PCa), accounting for 15% of all cancers [1], represents one of the most prevalent cancer entities and the fifth leading cause of cancer-specific death among men [2]

  • Whether the advantages of robot-assisted RP (RARP) over laparoscopic RP (LRP) can bring about better functional preservation and cancer control for PCa patients with a large Prostate volume (PV) has not been discussed to date, which is of clinical importance

  • Our results collectively demonstrate the superiority of RARP over LRP in promoting urinary continence (UC) recovery and preserving erectile function (EF) without compromising cancer cure for localized PCa with a large PV (≥50 ml)

Read more

Summary

Introduction

Prostate cancer (PCa), accounting for 15% of all cancers [1], represents one of the most prevalent cancer entities and the fifth leading cause of cancer-specific death among men [2]. The rate of patients diagnosed with localized PCa has dramatically increased following the extensive implementation of prostatespecific antigen (PSA) screening [3]. A very common condition among the aging male population, has demonstrated increased prevalence over the years [4, 5]. The mean size of prostates removed during radical prostatectomy (RP) has proportionately increased compared to that before the widespread application of PSA testing [6]. Prostate volume (PV) is considered a predictor of adverse disease features and disease recurrence after RP [7]. Larger PVs are closely associated with limited mobility in cases of small pelvis and narrowed visualization during RP, posing considerable challenges to treatment targeting functional protection and oncologic control [8, 9]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call